The Hox11 gene is essential for cell survival during spleen development.

The HOX11 homeobox gene was identified via the translocation t(10;14) in T cell leukaemia. To determine the function of this gene in mice, null mutations were made using homologous recombination in ES cells to incorporate lacZ into the hox11 transcription unit. Production of beta-galactosidase from the recombinant hox11 allele in +/- mutants allowed identification of sites of hox11 expression which included the developing spleen. Newborn hox11 -/- mice exhibit asplenia. Spleen formation commences normally at E11.5 in hox11 -/- mutant embryos but the spleen anlage undergoes rapid and complete resorption between E12.5 and E13.5. Dying spleen cells exhibit molecular features of apoptosis, suggesting that programmed cell death is initiated at this stage of organ development in the absence of hox11 protein. Thus hox11 is not required to initiate spleen development but is essential for the survival of splenic precursors during organogenesis. This function for hox11 suggests that enhanced cell survival may result from the t(10;14) which activates HOX11 in T cell leukaemias, further strengthening the association between oncogene-induced cell survival and tumorigenesis.

[1]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[2]  R. Krumlauf.  Hox genes in vertebrate development , 1994, Cell.

[3]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[4]  S. Korsmeyer,et al.  Hox11 controls the genesis of the spleen , 1994, Nature.

[5]  D. Bredesen,et al.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.

[6]  S. Kamel‐Reid,et al.  Characterization and developmental expression of Tlx-1, the murine homolog of HOX11 , 1993, Mechanisms of Development.

[7]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[8]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[9]  T. Rabbitts,et al.  The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Haslett,et al.  Phagocyte recognition of cells undergoing apoptosis. , 1993, Immunology today.

[11]  A. Ho,et al.  Genomic organization of the putative human homeobox proto-oncogene HOX-11 (TCL-3) and its endogenous expression in T cells. , 1992, Oncogene.

[12]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[13]  Suzanne Cory,et al.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.

[14]  S. Korsmeyer,et al.  bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.

[15]  T. Rabbitts,et al.  HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Lu,et al.  The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.

[17]  S. Korsmeyer,et al.  Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.

[18]  T. McDonnell,et al.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.

[19]  S. Raimondi,et al.  A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). , 1991, Blood.

[20]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[21]  S. Korsmeyer,et al.  The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Rabbitts,et al.  Alternating purine‐pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. , 1989, The EMBO journal.

[23]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[24]  D. G. Cran,et al.  Transgenes as probes for active chromosomal domains in mouse development , 1988, Nature.

[25]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[26]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[27]  A. Wyllie,et al.  Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.

[28]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.